Two Drugs Better Than One for Pulmonary HypertensionTwo Drugs Better Than One for Pulmonary Hypertension

New data from the AMBITION trial suggest that combining ambrisentan with tadalafil cuts clinical failure in pulmonary hypertension by 50% compared with either drug alone. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news